from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2240c/-

LFCtreatmentdescriptionclass of inhibitor

-0.469

Amikacinug/mL Amikacintranslation

-0.264

Cap5-10ug/mL Capreomycintranslation

0.173

Rox10-50 ug/mL Roxithromycintranslation

-0.411

SM2-5 ug/mL Streptomycintranslation

1.199

Tet5-10 ug/mL Tetracyclinetranslation

0.573

Rif0.2-5ug/mL Rifampicintranscription

0.436

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.328

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.742

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.212

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.269

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.178

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.339

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.374

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.315

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.684

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.344

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.172

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.013

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.231

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.409

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.445

Nigericin50 uM Nigericinrespiration

-0.093

TRC10-150 ug/mL Triclosanrespiration

-0.114

TRZ10-25 ug/mL Thioridazinerespiration

-1.118

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.301

menadione6-10 ug/mL Menadionerespiration

0.189

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.230

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.001

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.023

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.105

NRP_1Non-replicating persistence stage 1dosRassociated

-0.292

Amp0.2mg/mL AmpicillincellWall

-0.400

Cephalexin20-100 ug/mL CephalexincellWall

0.407

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.310

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.515

EMB10-20 ug/mL EthambutolcellWall

-0.434

Eta12-40 ug/mL EthionamidecellWall

-0.188

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.435

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.319

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.193

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.165

BZA0.12 mg/mL BenzamidearomaticAmides

0.570

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.669

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.477

H2O24 mM hydrogen peroxideDNAdamaging

-0.110

Levo10 ug/mL LevofloxacinDNAdamaging

0.323

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.333

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.271

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.285

UVUV-irradiationDNAdamaging

-0.258

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.574

Antimycin12.5-50 ug/mL Antimycin A?

-0.772

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.285

PA_110-50 ug/mL Antitubercular compound PA-1?

0.599

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.459

PA8240.2-2 ug/mL PA-824?

-1.268

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.326

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.319

Verapamil50 uM Verapamil?

-1.045

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.028

methoxatin10-20 ug/mL Methoxatin?